Overview

Study of rhASB in Patients With Mucopolysaccharidosis VI

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term efficacy and safety of rhASB treatment in patients with Mucopolysaccharidosis VI.
Phase:
Phase 3
Details
Lead Sponsor:
BioMarin Pharmaceutical